NCT02216799View on ClinicalTrials.gov

Glargine Insulin vs.Continuous Regular Insulin in Diabetic Surgical Patients Receiving Parenteral Nutrition (GLUCOSE-in-PN)

PHASE4CompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

August 31, 2015

Study Completion Date

August 31, 2015

Conditions
Diabetic Patients With Gastrointestinal Cancer Undergoing Surgery and Receiving Parenteral Nutrition
Interventions
DRUG

Glargine Insulin

80% of the insulin doses administrated via sliding scale will be administered every night as insulin glargine

DRUG

Regular insulin

80% of the Regular insulin administrated via sliding scale will be will be added to TPN bag to run over 24 hours

Trial Locations (1)

11211

King Faisal Specialist Hospital & Research Centre, Riyadh

All Listed Sponsors
lead

King Faisal Specialist Hospital & Research Center

OTHER

NCT02216799 - Glargine Insulin vs.Continuous Regular Insulin in Diabetic Surgical Patients Receiving Parenteral Nutrition (GLUCOSE-in-PN) | Biotech Hunter | Biotech Hunter